Barrow Robert's Form 4 filing
Definium Therapeutics, Inc. (DFTX) · filed Aug 20, 2024
- Accession no.
- 0000950170-24-099351
- Filed
- Aug 20, 2024
- Trade date
- Aug 19-20, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $6.21K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barrow RobertCIK 0001897557 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Common Shares | PPurchaseAcquired | +500 | $6.31 | +$3,155 | 565,043 | Direct | |
| Aug 20, 2024 | Common Shares | PPurchaseAcquired | +500 | $6.12 | +$3,060 | 565,543 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.